Clinical Study

Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study

Table 2

Multivariate logistic regression analysis of risk factors for the recurrence of retinopathy of prematurity.

FactorOdds ratio value

Birth 0.8230.860
Gestation 1.3320.791
Respiratory distress syndrome5.2320.221
HIE3.856E50.999
Hypotension0.0001.000
Carbohemia0.0001.000
Placental abruption0.0000.999
Preretinal hemorrhage before treatment39.4040.004
Preretinal hemorrhage after treatment0.0000.999
Iris neovascularization7.025E81.000
Threshold0.7730.883

HIE: hypoxic ischemic encephalopathy.